This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bauer SB, Hallett M, Khoshbin S, et al. Predictive value of urodynamic evaluation in newborns with myelodysplasia. J Am Med Assoc 1984; 252:650–652.
McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981; 126:205–209.
Van Gool J. Neuropathic and non-neuropathic bladder-sphincter dysfunction in children. Pediatr Adoles Med 1994;5:178–182.
Baskin LS, Kogan BA, Benard F. Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol 1990; 66:532–534.
Joseph DB, Bauer SB, Colodny AH, et al. Clean, intermittent catheterization of infants with neurogenic bladder. Pediatrics 1989; 84:78–82.
Edelstein RA, Bauer SB, Kelly MD, et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 1995; 154:1500–1504.
Hernandez RD, Hurwitz RS, Foote JE, et al. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol 1994; 152(5Pt 1):1582–1585.
Schurch B, Stohrer M, Kramer G, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164(3 Pt 1):692–697.
Reitz A, Stohrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45:510–515.
Schurch B, de Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005; 174:196–200
Mall V, Glocker FX, Frankenschmidt A, Gordjani N, Heinen F, Brandis M, Korinthenberg R. Treatment of neuropathic bladder using botulinum toxin A in a 1-year-old child with myelomeningocele. Pediatr Nephrol 2001; 16:1161–1162.
Schulte-Baukloh H, Knispel HH, Michael T. Botulinum-A toxin in the treatment of neurogenic bladder in children. Pediatrics 2002; 110(2 Pt 1):420–421.
Schulte-Baukloh H, Michael T, Sturzebecher B, Knispel HH. Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 2003; 44:139–143
Riccabona M, Koen M, Schindler M, et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 2004; 171(2 Pt 1):845–848.
Corcos J, Al-Taweed W, Robichaud C. Botulinum toxin as an alternative treatment to bladder augmentation in children with neurogenic bladder due to myelomeningocele. J Urol 2004; 171:181
Drachman D. Botulinum toxin as a tool for research in the nervous system. In: Simspon L, editor. Neuropoisons: their pathophysiological actions. New York: Plenum Press; 1971. pp. 325–347.
Coffield J, Considine R, Simspon L. The site and mechanism of action of botulinum neurotoxin. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. pp. 3–14.
Smith CP, Franks ME, McNeil BK, et al. Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 2003; 169:1896–1900.
MacKenzie I, Burnstock G, Dolly JO. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 1982; 7:997–1006.
Smith C, Fraser M, Bartho L, et al. Botulinum toxin A inhibits afferent nerve evoked bladder strip contractions. J Urol 2002;167:41.
Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990; 40:277–280.
Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB, Dasgupta P, Fowler CJ, Anand P: Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005; 174:977–983.
DeLaet K, Wyndaele JJ. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord 2005; 43:397–399.
Brin MF, Blitzer A. Botulinum toxin: dangerous terminology errors. J R Soc Med 1993; 86:493–494.
Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994; 9:31–39.
Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993; 43:834–836.
Grosse J, Kramer G, Stöhrer M. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005;47:653–659
Haferkamp A, Schurch B, Reitz A, et al. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type an in overactive neurogenic bladder. Eur Urol 2004; 46:784–791.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schurch, B., Karsenty, G., Corcos, J. (2006). Botulinum Toxin Injections to Treat Neurogenic Bladder — Sphincter Dysfunction in Pediatric Patients. In: Esposito, C., Guys, J.M., Gough, D., Savanelli, A. (eds) Pediatric Neurogenic Bladder Dysfunction. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30867-9_24
Download citation
DOI: https://doi.org/10.1007/3-540-30867-9_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30866-9
Online ISBN: 978-3-540-30867-6
eBook Packages: MedicineMedicine (R0)